Regulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path Forward [0.03%]
大麻和大麻素的研究障碍及未来之路
Daniele Piomelli,Robert Solomon,Donald Abrams et al.
Daniele Piomelli et al.
Analysis of 2-Arachidonoylglycerol Levels in Polycystic Ovary Syndrome in the Context of Hormonal and Metabolic Alterations and Across the Classical Phenotypes [0.03%]
多囊卵巢综合征激素和代谢改变背景下分析2-花生四烯酸甘油水平及经典表型差异
Plamena Kabakchieva,Antoaneta Gateva,Julieta Hristova et al.
Plamena Kabakchieva et al.
Introduction: Ovarian folliculogenesis requires a fine balance between extra- and intra-ovarian factors. Endocannabinoids are found in the female reproductive system and are essential for a normal follicular growing process and ovulation. F...
Cannabidiol, a Regulator of Intracellular Calcium and Calpain [0.03%]
cannabidiol ，一种调节胞内钙离子和钙蛋白酶的物质
Kyung-Hwa Jeon,Sang-Hyuck Park,Woong Jin Bae et al.
Kyung-Hwa Jeon et al.
Cannabidiol (CBD) is one of the most abundant components of Cannabis and has long been used in Cannabis-based preparations. Recently, CBD has become a promising pharmacological agent because of its beneficial properties in the pathophysiolo...
Cannabinoid Type 2 Receptor Activation Reduces the Progression of Kidney Fibrosis Using a Mouse Model of Unilateral Ureteral Obstruction [0.03%]
大麻素受体2型激活通过小鼠单侧输尿管梗阻模型减少肾纤维化的发展进展
Mallory L Swanson,Kevin R Regner,Bob M Moore nd et al.
Mallory L Swanson et al.
Background: Kidney fibrosis is a hallmark consequence of all forms of chronic kidney disease with few available treatment modalities. Material and Methods: In this study, we performed the unilateral ureteral obstruction (UUO) procedure to i...
Letter to the Editor: Parental Behaviors and Cannabis-Related Harm Reduction in College [0.03%]
写给编辑室的信：家长行为与大学里的大麻相关伤害的减少措施
Caitlin C Abar,Bonnie Rose Thomson,Allison Miley et al.
Caitlin C Abar et al.
Endometriosis and Cannabis Consumption During the COVID-19 Pandemic: An International Cross-Sectional Survey [0.03%]
新冠肺炎大流行下的子宫内膜异位症与大麻使用：一项国际横断面调查研究
Mike Armour,Justin Sinclair,Junipearl Cheng et al.
Mike Armour et al.
Introduction: Endometriosis affects 1 in 10 women worldwide, with most experiencing difficulties achieving adequate symptom control. These difficulties have been compounded by the onset of the COVID-19 pandemic due to worldwide shifts in he...
Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States [0.03%]
美国成人新冠肺炎疫情期间大麻医疗使用的转变：一项网络调查研究
Stephanie Lake,Ryan D Assaf,Pamina M Gorbach et al.
Stephanie Lake et al.
Background: The COVID-19 pandemic has had widespread impacts on mental health and substance use. While increases in nonmedical cannabis use during COVID-19 have been documented among people who use cannabis across a diversity of settings, c...
An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry [0.03%]
英国医疗用大麻登记处患者的临床结果测量的最新分析
Mehmet Ergisi,Simon Erridge,Michael Harris et al.
Mehmet Ergisi et al.
Introduction: There is a growing body of literature supporting the efficacy of cannabis-based medicinal products (CBMPs). Despite an increase in prescribing globally, there is a paucity of high-quality clinical data on the efficacy of CBMPs...
Caroline A MacCallum,Lindsay A Lo,Carly A Pistawka et al.
Caroline A MacCallum et al.
Increase in medical cannabis use, along with available products, warrants the need for clinicians to be knowledgeable in evaluating the quality of any cannabis product presented in clinical practice. Determining whether a product is regulat...